Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Labeled cells in patients with malignancy.

J P Dutcher

    Seminars in Nuclear Medicine
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Radioisotope cell labeling, including indium-111, aids hematology research by tracking normal and malignant cell migration. This technique offers insights into diseases and infection localization, though cell function concerns are under investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIM<sup>SM</sup> registry.

    Journal for immunotherapy of cancer·2019
    Same author

    A phase I study of cabozantinib (XL184) in patients with renal cell cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Characterization of bone metastases in patients with renal cell cancer.

    BJU international·2004
    Same author

    Accelerated and blastic phase of chronic myeloid leukemia.

    Current treatment options in oncology·2002
    Same author

    Phase I study of recombinant human CD40 ligand in cancer patients.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
    Same author

    Angiogenesis and melanoma.

    Current oncology reports·2001
    Same journal

    Letter from the Editors.

    Seminars in nuclear medicine·2026
    Same journal

    Expanding Horizons: The Role of Kaleidoscope and Relevant Images in Seminars in Nuclear Medicine.

    Seminars in nuclear medicine·2026
    Same journal

    The diagnostic performance and clinical value of [18F]FDG PET/CT in pleural mesothelioma - A systematic review and meta-analysis.

    Seminars in nuclear medicine·2026
    Same journal

    Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.

    Seminars in nuclear medicine·2026
    Same journal

    <sup>18</sup>F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.

    Seminars in nuclear medicine·2026
    Same journal

    Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.

    Seminars in nuclear medicine·2026
    See all related articles

    Area of Science:

    • Hematology
    • Nuclear Medicine
    • Oncology

    Background:

    • Radioisotopes like Chromium-51 have long been used for cell labeling in hematology.
    • Lymphocyte recirculation patterns are well-established.
    • Newer radioisotopes offer advanced imaging for disease research.

    Purpose of the Study:

    • To explore the application of radioisotope cell labeling, specifically indium-111, in studying cell migration.
    • To investigate the migration patterns of normal and malignant cells in various diseases.
    • To assess the diagnostic and therapeutic potential of radioisotope labeling in hematologic malignancies.

    Main Methods:

    • In vivo studies using indium-111 to label and track cells in animal models and human patients.
    • Comparison of migration patterns between normal, malignant, and lymphoid cells.

    Related Experiment Videos

  • Evaluation of indium-111 labeled granulocytes for infection localization and transfusion benefit assessment.

    • Main Results:

    • Indium-111 imaging provides insights into the migration of normal and malignant cells, including distinct patterns for carcinoma and lymphoid cells.
    • Studies revealed different migration behaviors in chronic lymphocytic leukemia and well-differentiated lymphoma.
    • Indium-111 labeled granulocytes show diagnostic utility for infection and potential in evaluating granulocyte transfusions.

    Conclusions:

    • Radioisotope cell labeling with indium-111 enhances understanding of cell migration in hematologic and malignant diseases.
    • The technique shows promise for improving diagnostics and therapeutic strategies in oncology.
    • Further investigation is needed regarding potential long-term effects of radioisotopes on cell function.